glp-1 website Fridays | Telehealth 💉 Using Mounjaro®, Wegovy®, Ozempic®

*Average weight loss based on 68 and 72 week clinical trials studying semaglutide (2.4 mg) and tirzepatide (10-15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related health condition, the average weight loss was 15% and 20% respectively

Retatrutide is the agonist of GLP-1 receptor, GIP receptor, and glucagon (GCG) receptor, which can reduce body weight and improve blood glucose by subcutaneous injection once a week(Rosenstock et al 2023)

4.2% said they got a prescription from a specialist

Intraduodenal administration of sucrose, sucralose, and the artificial sweetener PALSWEET each significantly increase lymph GLP-2 output compared to saline control (Sato et al., 2013)

GLP-1 functions in the regulation of blood glucose through insulin, and plays a role in obesity and diabetes